Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device
CompletedNot applicableNCT04871581
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Single blinding study comparing FDA cleared device for prevention of medically diagnosed migraine pain to placebo.
Study details
- Official title
- Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device: Overview and Results of a Placebo-Controlled Crossover Study
- Conditions
- Interventions
- Device: NTI-tss
- Device: Placebo
- Sponsor
- ChairsideSplint.com
- Start date
- 2019-10-01
- Primary completion
- 2020-06-30
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Diagnosed with chronic migraine at a neurology clinic - Exclusion Criteria: none \-
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04871581